Eric Thibaudeau

Eric Thibaudeau began their work experience at Caprion Pharmaceuticals in 2000, where they held two roles as a Senior Scientist. Eric managed various projects, including the implementation and improvement of high throughput sample processing processes and the development of plasma depletion methods for proteomic analysis. Eric also managed studies related to mechanism of action, efficacy, toxicology, and toxicokinetics in the oncology program.

In 2009, Eric moved on to work at Thallion Pharmaceuticals as a Project Manager. In this role, they were responsible for managing efficacy, toxicology, and PK/PD studies for oncology programs. Eric also oversaw the development and implementation of biomarker assays and method validation processes.

Eric then worked at Amadeus Pharma Services as the Director of Consulting Services for a brief period in 2009. Eric later joined Variation Biotechnologies as a Project Manager in the same year, managing projects related to biotechnology.

From 2010 to 2016, Eric worked at the Montreal Heart Institute as a Project Manager. During their time there, they managed various projects within the institute.

Most recently, Eric has been working at Turnstone Biologics since 2016. Eric started as a Senior Manager in Project Management Technical Operations and eventually transitioned to the role of Associate Director in Finance.

Eric Thibaudeau has a comprehensive education history. Eric pursued a Bachelor of Science (B.Sc) in Microbiology from Université Laval between 1991 and 1994. Following their undergraduate studies, they continued their academic journey at the same institution and obtained a Master of Science (M.Sc) in Molecular & Cellular Biology from 1994 to 1996. After a considerable gap, Eric returned to Université Laval in 2021 to pursue a Certificate in Law, which is set to be completed in 2024.